litlas
Log inCreate account

Maria De Santis

Active 2001–2025

170
Papers
31,925
Citations
74
h-index
150
i10-index

Citations

Citations per year for Maria De Santis1982: 1 citations1985: 1 citations1998: 1 citations2000: 3 citations2002: 2 citations2003: 4 citations2004: 6 citations2005: 5 citations2006: 5 citations2007: 10 citations2008: 22 citations2009: 34 citations2010: 57 citations2011: 62 citations2012: 72 citations2013: 67 citations2014: 84 citations2015: 78 citations2016: 105 citations2017: 172 citations2018: 201 citations2019: 938 citations2020: 1,144 citations2021: 1,217 citations2022: 1,012 citations2023: 748 citations2024: 1,421 citations2025: 734 citations2026: 26 citations1983–1984: no citations, so these years are not shown1986–1997: no citations, so these years are not shown1999: no citations, so this year is not shown2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,113 citing papers, 14.5% of this breakdownItaly: 1,313 citing papers, 9% of this breakdownChina: 1,283 citing papers, 8.8% of this breakdownGermany: 1,066 citing papers, 7.3% of this breakdownUnited Kingdom: 970 citing papers, 6.7% of this breakdownFrance: 726 citing papers, 5% of this breakdownNetherlands: 677 citing papers, 4.7% of this breakdownCanada: 556 citing papers, 3.8% of this breakdownSpain: 500 citing papers, 3.4% of this breakdownSwitzerland: 473 citing papers, 3.3% of this breakdownJapan: 401 citing papers, 2.8% of this breakdownBelgium: 364 citing papers, 2.5% of this breakdown
0%14.5%Other 28.2%

Institutions

Fields

  • Medicine86.1%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Immunology and Microbiology2.1%
  • Engineering1%
  • Computer Science0.6%
  • Physics and Astronomy0.3%
  • Other1.7%

Topics

  • Prostate Cancer Treatment and Research11.6%
  • Prostate Cancer Diagnosis and Treatment11.6%
  • Bladder and Urothelial Cancer Treatments7.5%
  • Urinary and Genital Oncology Studies3.6%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Radiopharmaceutical Chemistry and Applications2.4%
  • Other60.4%

Coauthors

All papers

Open in search
  1. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    Authors: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, Nikos Grivas, Jeremy Grummet, Ann Henry, Theodorus van der Kwast, Thomas Lam, Michael Lardas, Matthew Liew, Malcolm D. Mason, Lisa Moris, Daniela E. Oprea‐Lager, Henk G. van der Poel, Olivier Rouvière, Ivo G. Schoots, Derya Tilki, Thomas Wiegel, Peter-Paul Willemse, Philip Cornford - European Urology 2020 cited by 2,814

  2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent

    Authors: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Oliver Brunckhorst, Julie Darraugh, Daniel Eberli, Gert De Meerleer, Maria De Santis, Andrea Farolfi, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Ann Henry, Michael Lardas, Geert J.L.H. van Leenders, Matthew Liew, Estefanía Linares, Jan Oldenburg, Inge M. van Oort, Daniela E. Oprea‐Lager, Guillaume Ploussard, Matthew J. Roberts, Olivier Rouvière, Ivo G. Schoots, Natasha Schouten, Emma Jane Smith, Johan Stranne, Thomas Wiegel, Peter-Paul Willemse, Derya Tilki - European Urology 2024 cited by 1,087

  3. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: Tom Powles, Joaquim Bellmunt, Éva Compérat, Maria De Santis, Robert Huddart, Yohann Loriot, Andrea Necchi, Begoña P. Valderrama, Alain Ravaud, Shahrokh F. Shariat, Bernadett Szabados, Michiel S. van der Heijden, Silke Gillessen - Annals of Oncology 2021 cited by 525

  4. Current best practice for bladder cancer: a narrative review of diagnostics and treatments

    Authors: Éva Compérat, Mahul B. Amin, Richard Cathomas, Ananya Choudhury, Maria De Santis, Ashish M. Kamat, Arnulf Stenzl, Harriet C. Thoeny, J. Alfred Witjes - The Lancet 2022 cited by 434

  5. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer

    Authors: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Jeremy Grummet, Ann Henry, Theodorus van der Kwast, Thomas Lam, Michael Lardas, Matthew Liew, Malcolm D. Mason, Lisa Moris, Daniela E. Oprea‐Lager, Henk G. van der Poel, Olivier Rouvière, Ivo G. Schoots, Derya Tilki, Thomas Wiegel, Peter-Paul Willemse, Nicolas Mottet - European Urology 2020 cited by 1,126

  6. Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

    Authors: Matthew D. Galsky, Jóse Ángel Arranz Arija, Aristotelis Bamias, Ian D. Davis, Maria De Santis, Eiji Kikuchi, Xavier García del Muro, Ugo De Giorgi, Marina Mencinger, Kouji Izumi, Stefano Panni, Mahmut Gümüş, Mustafa Özgüroğlu, Arash Rezazadeh Kalebasty, Se Hoon Park, B. Yа. Alekseev, Fabio A. Schutz, Jian-Ri Li, Dingwei Ye, Nicholas J. Vogelzang, Sandrine Bernhard, Darren Tayama, Sanjeev Mariathasan, Almut Mecke, AnnChristine Thåström, Enrique Grande - The Lancet 2020 cited by 787

  7. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    Authors: Nicolas Mottet, Joaquim Bellmunt, M. Bolla, Erik Briers, Marcus Cumberbatch, Maria De Santis, Nicola Fossati, Tobias Gross, Ann Henry, Steven Joniau, Thomas Lam, Malcolm D. Mason, В. Б. Матвеев, Paul C. Moldovan, Roderick C.N. van den Bergh, Thomas Van den Broeck, Henk G. van der Poel, Theodorus van der Kwast, Olivier Rouvière, Ivo G. Schoots, Thomas Wiegel, Philip Cornford - European Urology 2016 cited by 3,260

  8. Mapping and predicting mortality from systemic sclerosis

    Authors: Muriel Elhaï, Christophe Meune, Marouane Boubaya, Jérôme Avouac, É. Hachulla, Alexandra Balbir‐Gurman, Gabriela Riemekasten, Paolo Airò, Beatriz Joven, Serena Vettori, Franco Cozzi, Susanne Ullman, László Czirják, Mohammed Tikly, Ulf Müller‐Ladner, Paola Caramaschi, Oliver Distler, Florenzo Iannone, Lidia P Ananieva, Roger Hesselstrand, Radim Bečvář, Armando Gabrielli, Nemanja Damjanov, Maria João Salvador, Valeria Riccieri, Carina Mihai, Gabriella Szűcs, Ulrich A. Walker, Nicolas Hunzelmann, Duška Martinović, Vanessa Smith, Carolina de Souza Müller, Carlomaurizio Montecucco, Daniela Opriș-Belinski, Francesca Ingegnoli, Panayiotis G. Vlachoyiannopoulos, Bojana Stamenković, Edoardo Rosato, Stefan Heitmann, Jörg H. W. Distler, Thierry Zénone, Matthias Seidel, Alessandra Vacca, Ellen De Langhe, Srđan Novak, Maurizio Cutolo, Luc Mouthon, Jörg Henes, Carlo Chizzolini, Carlos Alberto von Mühlen, Kamal Solanki, Simona Rednic, Lisa K. Stamp, Branimir Anić, Vera Ortiz-Santamaría, Maria De Santis, Şule Yavuz, Walter Alberto Sifuentes Giraldo, Emmanuel Chatelus, Jiří Štork, Jacob M. van Laar, Esthela Loyo, Paloma García de la Peña Lefebvre, Kilian Eyerich, Vanesa Cosentino, Juan José Alegre Sancho, Otylia Kowal‐Bielecka, Grégoire Rey, Marco Matucci‐Cerinic, Yannick Allanore - Annals of the Rheumatic Diseases 2017 cited by 684

  9. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review

    Authors: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, Tobias Gross, Lisa Moris, Erik Briers, Marcus Cumberbatch, Maria De Santis, Derya Tilki, Stefano Fanti, Nicola Fossati, Silke Gillessen, Jeremy Grummet, Ann Henry, Michael Lardas, Matthew Liew, Olivier Rouvière, Jakub Pecanka, Malcolm D. Mason, Ivo G. Schoots, Theodorus van der Kwast, Henk G. van der Poel, Thomas Wiegel, Peter-Paul M. Willemse, Yuhong Yuan, Thomas Lam, Philip Cornford, Nicolas Mottet - European Urology 2018 cited by 517

  10. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer

    Authors: Derya Tilki, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Oliver Brunckhorst, Julie Darraugh, Daniel Eberli, Gert De Meerleer, Maria De Santis, Andrea Farolfi, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Ann Henry, Michael Lardas, Geert J.L.H. van Leenders, Matthew Liew, Estefania Linares Espinos, Jan Oldenburg, Inge M. van Oort, Daniela E. Oprea‐Lager, Guillaume Ploussard, Matthew J. Roberts, Olivier Rouvière, Ivo G. Schoots, Natasha Schouten, Emma Jane Smith, Johan Stranne, Thomas Wiegel, Peter-Paul Willemse, Philip Cornford - European Urology 2024 cited by 313

  11. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    Authors: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Journal of Cancer 2023 cited by 157

  12. Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial

    Authors: Emmanuel S. Antonarakis, Se Hoon Park, Jeffrey C. Goh, Sang Joon Shin, Jae‐Lyun Lee, Niven Mehra, Ray McDermott, Núria Sala‐González, Peter C.C. Fong, Richard Greil, Margitta Retz, Juan Pablo Sade, Patricio Yañez, Eric Yi‐Hsiu Huang, Stephen Begbie, Rustem Gafanov, Maria De Santis, Eli Rosenbaum, Michael Kolinsky, Felipe Rey, Kun‐Yuan Chiu, Guilhem Roubaud, Gero Kramer, Makoto Sumitomo, Francesco Massari, Hiroyoshi Suzuki, Ping Qiu, Jinchun Zhang, Jeri Kim, Christian Poehlein, Evan Y. Yu - Journal of Clinical Oncology 2023 cited by 132

  13. Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Joaquim Bellmunt, Anna Orsola, Thomas Wiegel, Marta Guix, Maria De Santis, Vesa Kataja - Annals of Oncology 2011 cited by 249

  14. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

    Authors: Philip Cornford, Joaquim Bellmunt, M. Bolla, Erik Briers, Maria De Santis, Tobias Gross, Ann Henry, Steven Joniau, Thomas Lam, Malcolm D. Mason, Henk G. van der Poel, Theodorus van der Kwast, Olivier Rouvière, Thomas Wiegel, Nicolas Mottet - European Urology 2016 cited by 1,442

  15. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review

    Authors: Nicola Fossati, Peter-Paul Willemse, Thomas Van den Broeck, Roderick C.N. van den Bergh, Cathy Yuhong Yuan, Erik Briers, Joaquim Bellmunt, M. Bolla, Philip Cornford, Maria De Santis, Ekelechi MacPepple, Ann Henry, Malcolm D. Mason, В. Б. Матвеев, Henk G. van der Poel, Theodorus van der Kwast, Olivier Rouvière, Ivo G. Schoots, Thomas Wiegel, Thomas Lam, Nicolas Mottet, Steven Joniau - European Urology 2017 cited by 533

  16. ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma

    Authors: Thomas Powles, Joaquim Bellmunt, Éva Compérat, Maria De Santis, Robert Huddart, Yohann Loriot, Andrea Necchi, Begoña P. Valderrama, Alain Ravaud, Shahrokh F. Shariat, Bernadett Szabados, Michiel S. van der Heijden, Silke Gillessen - Annals of Oncology 2024 cited by 159

  17. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

    Authors: J. Alfred Witjes, Thierry Lebrét, Éva Compérat, Nigel C. Cowan, Maria De Santis, H.M. Bruins, Virginia Hernández, Estefanía Linares, James Dunn, Mathieu Rouanne, Y. Neuzillet, Erik Veskimäe, Antoine G. van der Heijden, Georgios Gakis, María J. Ribal - European Urology 2016 cited by 1,508

  18. Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

    Authors: Maria De Santis, Joaquim Bellmunt, Graham M. Mead, J. Martijn Kerst, Michael Leahy, Pablo Maroto, Thierry Gil, Sandrine Marréaud, Gedske Daugaard, Iwona Skoneczna, Sandra Collette, Julie Lorent, Ronald de Wit, Richard Sylvester - Journal of Clinical Oncology 2011 cited by 773

  19. Viral Respiratory Pathogens and Lung Injury

    Authors: Nicola Clementi, Sreya Ghosh, Maria De Santis, Matteo Castelli, Elena Criscuolo, Ivan Zanoni, Massimo Clementi, Nicasio Mancini - Clinical Microbiology Reviews 2021 cited by 184

  20. Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

    Authors: Toni K. Choueiri, Thomas Powles, Katriina Peltola, Guillermo de Velasco, Mauricio Burotto, Cristina Suárez, Pooja Ghatalia, Roberto Iacovelli, Elaine T. Lam, Elena Verzoni, Mahmut Gümüş, Walter M. Stadler, Christian Kollmannsberger, Bohuslav Melichar, Balaji Venugopal, Marine Gross‐Goupil, Alexandr Poprach, Maria De Santis, Fabio A. Schutz, Se Hoon Park, Dmitry Nosov, Camillo Porta, Jae‐Lyun Lee, Xavier García del Muro, Elisa Biscaldi, Ray Manneh Kopp, Mototsugu Oya, He Li, Aobo Wang, Rodolfo F. Perini, Donna Vickery, Laurence Albigès, Brian I. Rini - New England Journal of Medicine 2024 cited by 142

  21. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    Authors: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Urology 2022 cited by 118

  22. Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations

    Authors: Thomas Van den Broeck, Roderick C.N. van den Bergh, Erik Briers, Philip Cornford, Marcus Cumberbatch, Derya Tilki, Maria De Santis, Stefano Fanti, Nicola Fossati, Silke Gillessen, Jeremy Grummet, Ann Henry, Michael Lardas, Matthew Liew, Malcolm D. Mason, Lisa Moris, Ivo G. Schoots, Theodorus van der Kwast, Henk G. van der Poel, Thomas Wiegel, Peter-Paul M. Willemse, Olivier Rouvière, Thomas Lam, Nicolas Mottet - European Urology Focus 2019 cited by 242

  23. Pasotuxizumab, a Bite ® Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings

    Authors: Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich, Ruth Seggewiß-Bernhardt, Barbara Deschler-Baier, Manik Chatterjee, Maria-Elisabeth Goebeler, Kurt Miller, Maria De Santis, Wolfgang Loidl, Christian Dittrich, Andreas K. Buck, Constantin Lapa, Annette Thurner, Sabine Wittemer‐Rump, Gökben Koca, Oliver Boix, Wolf‐Dietrich Döcke, Ricarda Finnern, Helena Kusi, Antoinette Ajavon‐Hartmann, Sabine Stienen, Cyrus Sayehli, Bülent Polat, Ralf C. Bargou - Immunotherapy 2020 cited by 144

  24. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study

    Authors: Enrique Grande, José Ángel Arranz, Maria De Santis, Aristotelis Bamias, Eiji Kikuchi, Xavier García del Muro, Se Hoon Park, Ugo De Giorgi, B. Yа. Alekseev, Marina Mencinger, Kouji Izumi, Fabio A.B. Schutz, Javier Puente, Jian‐Ri Li, Peter H. O’Donnell, Arash Rezazadeh Kalebasty, Dingwei Ye, Sanjeev Mariathasan, FabioIa Bene-Tchaleu, Sandrine Bernhard, Chooi Lee, Ian D. Davis, Matthew D. Galsky - The Lancet Oncology 2023 cited by 55